نبذة مختصرة : This article is a literature review on the management of patients with acute cough. The classification of cough, the main causes of acute and subacute cough, the current view on the etiology and pathogenesis of chronic cough are presented. Cough is an important protective mechanism, but in acute and chronic diseases of the bronchopulmonary system cough significantly reduces the quality of life and causes numerous complications. The most common cause of acute and subacute cough is respiratory viruses. Chronic cough is currently explained by the theory of cough hypersensitivity, according to which chronic refractory cough is the result of hypersensitivity of the cough receptors. Before the cause of chronic cough is identified, and when treating patients with acute and subacute cough, symptomatic therapy with cough suppressants that eliminate increased cough reflex activity to normal levels regardless of cough etiology, although not affecting the pathophysiological mechanisms of cough, or with combined drugs with suppressant and expectorant effects, is often required. Peripheral suppressants reduce the activity of peripheral cough receptors of the upper airway mucosa by softening, moistening and enveloping. Central cough suppressants include butamirate. Central non-narcotic cough suppressants in various combinations with muco- and bronchodilators and antihistamines form part of many anti-cough medicines. Butamirate has a non-specific anticholinergic and therefore bronchodilator effect. This article presents a review of clinical studies on the efficacy of butamirate. ; Данная статья представляет собой обзор литературы, посвященный проблемам ведения больных с острым кашлем. Представлены классификация кашля, основные причины острого и подострого кашля, современный взгляд на этиологию и патогенез хронического кашля. Кашель – важный защитный механизм, однако при острых и хронических заболеваниях бронхолегочной системы кашель существенно снижает качество жизни и вызывает многочисленные осложнения. Наиболее ...
Relation: https://www.med-sovet.pro/jour/article/view/7125/6397; Raj A.A., Birring S.S. Clinical assessment of chronic cough severity. Pulm Pharmacol Ther. 2007;20(4):334–337. https://doi.org/10.1016/j.pupt.2006.10.002.; Song W.-J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., Chung K.F. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533–544. https://doi.org/10.1016/S2213-2600(21)00125-9.; Braman S.S. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl.):138S–146S. https://doi.org/10.1378/chest.129.1_suppl.138S.; Чикина С.Ю. Синдром кашлевой гиперчувствительности. Пульмонология. 2015;25(2):224–228. https://doi.org/10.18093/0869-0189-2015-25-2-224-228.; Song W.-J., Chang Y.-S., Morice A.H. Changing the paradigm for cough: does ‘cough hypersensitivity’ aid our understanding? Asia Pac Allergy. 2014;4(1):3–13. https://doi.org/10.5415/apallergy.2014.4.1.3.; Smit L.A.M., Kogevinas M., Anto J.M., Bouzigon E., González J.R., Le Moual N. et al. Transient receptor potential genes, smoking, occupational exposures and cough in adults. Respir Res. 2012;13(1):26. https://doi.org/10.1186/1465-9921-13-26.; Canning B.J. Afferent nerves regulating the cough reflex: mechanisms and mediators of cough in disease. Otolaryngol Clin North Am. 2010;43(1):15–25. https://doi.org/10.1016/j.otc.2009.11.012.; Kotzer C.J., Hay D.W., Dondio G., Giardina G., Petrillo P., Underwood D.C. The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther. 2000;292(2):803–809. Available at: https://pubmed.ncbi.nlm.nih.gov/10640321.; Irwin R.S., French C.L., Chang A.B., Altman K.W., CHEST Expert Cough Panel. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest. 2018;153(1):196–209. https://doi.org/10.1016/j.chest.2017.10.016.; Dicpinigaitis P.V., Colice G.L., Goolsby M.J., Rogg G.I., Spector S.L., Winther B. Acute cough: a diagnostic and therapeutic challenge. Cough. 2009;5:11. https://doi.org/10.1186/1745-9974-5-11.; Smith M.P., Lown M., Singh S., Ireland B., Hill A.T., Linder J.A. et al. Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients. CHEST Expert Panel Report. Chest. 2020;157(5):1256–1265. https://doi.org/10.1016/j.chest.2020.01.044.; Woodhead M., Blasi F., Ewig S., Garau J., Huchon G., Ieven M. et al. Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect. 2011;17(Suppl. 6):E1–59. https://doi.org/10.1111/j.1469-0691.2011.03672.x.; Rogers D.F. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007;52(9):1176–1193. Available at: https://pubmed.ncbi.nlm.nih.gov/17716385.; Амелина Е.Л., Анаев Э.Х., Красовский С.А., Романова Л.К., Симонова О.И., Черняев А.Л., Чикина С.Ю. Мукоактивная терапия. М.: Атмосфера; 2006. 129 с.; Morice A., Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Resp Res. 2016;3(1):e000137. https://doi.org/10.1136/bmjresp-2016-000137.; Lejeune J., Weibel M.A. Comparison of 2 antitussive agents in pediatrics (butamirate citrate in drinkable solution and zipeprol syrup). Rev Med Suisse Romande. 1990;110(2):181–185. Available at: https://pubmed.ncbi.nlm.nih.gov/2315598.; Germouty J., Weibel M.A. Clinical comparison of butamirate citrate with a codeine-based antitussive agent. Rev Med Suisse Romande. 1990;110(11):983–986. Available at: https://pubmed.ncbi.nlm.nih.gov/1980027.; Charpin J., Weibel M.A. Comparative evaluation of the antitussive activity of butamirate citrate linctus versus clobutinol syrup. Respiration. 1990;57(4):275–279. https://doi.org/10.1159/000195855.; Faruqi S., Wright C., Thompson R., Morice A.H. A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers. Br J Clin Pharmacol. 2014;78(6):1272–1280. https://doi.org/10.1111/bcp.12458.; Евстифеева Г.Ю., Трусова О.Ю., Данилова Е.И., Суменко В.В. Клиническая эффективность лечения кашля в педиатрической практике. Клиническая эффективность лечения кашля в педиатрической практике. Медицинский совет. 2019;(2):194–198. https://doi.org/10.21518/2079-701X-2019-2-194-198.; Smith S.M., Schroeder K., Fahey T. Over-the-counter (OTC) medications for acute cough in children andadults in community settings. Cochrane Database Syst Rev. 2014;2014(11):CD001831. https://doi.org/10.1002/14651858.CD001831.pub5.; Albrecht H.H., Dicpinigaitis P.V., Guenin E.P. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidiscip Respir Med. 2017;12:31. https://doi.org/10.1186/s40248-017-0113-4.; Holmes P.W., Barter C.E., Pierce R.J. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med. 1992;86(5):425–429. https://doi.org/10.1016/s0954-6111(06)80010-7.; Lee S.E., Lee J.H., Kim H.J., Lee B.J., Cho S.H., Price D. et al. Inhaled Corticosteroids and Placebo Treatment Effects in Adult Patients With Cough: A Systematic Review and Meta-analysis. Allergy Asthma Immunol Res. 2019;11(6):856–870. https://doi.org/10.4168/aair.2019.11.6.856.; https://www.med-sovet.pro/jour/article/view/7125
Rights: Authors publishing their articles in this journal shall agree to the following:Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY), which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the institute’s repository, publication in a book), with reference to its original publication in this journal.Authors have the right to post work on the Internet (for example, in the institute’s repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию.Авторы имеют право размещать работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу. (См. The Effect of Open Access).
Processing Request
No Comments.